Abstract
Since the use of Highly Active Antiretroviral Therapy (HAART) for HIV infection, there have been increasing reports of systemic manifestations of immune restoration. This new clinical syndrome among HIV-infected patients is associated with underlying co-infections with mycobacteria, cytomegalovirus, hepatitis B and C infections, etc.... We report on an HIV/tuberculosis (TB) co-infected patient who developed an immune restoration inflammatory syndrome after initiation of HAART and anti-TB treatment. She developed fever, large abscesses and pleural and peritoneal effusions. Systemic symptoms decreased during corticosteroid treatment, but abscesses only disappeared 8 months after the start of the anti-TB treatment.
MeSH terms
-
AIDS-Related Opportunistic Infections / diagnosis
-
AIDS-Related Opportunistic Infections / drug therapy*
-
AIDS-Related Opportunistic Infections / immunology
-
Abscess / etiology*
-
Abscess / physiopathology
-
Abscess / therapy
-
Adult
-
Anti-Bacterial Agents / administration & dosage
-
Antiretroviral Therapy, Highly Active / adverse effects*
-
Antiretroviral Therapy, Highly Active / methods
-
Antitubercular Agents / administration & dosage
-
Antitubercular Agents / adverse effects*
-
Belgium
-
Drainage
-
Drug Therapy, Combination
-
Female
-
Follow-Up Studies
-
Humans
-
Immunocompromised Host / immunology*
-
Lymphatic Diseases / diagnosis
-
Lymphatic Diseases / etiology*
-
Lymphatic Diseases / therapy
-
Risk Assessment
-
Treatment Outcome
-
Tuberculosis, Pulmonary / diagnosis
-
Tuberculosis, Pulmonary / drug therapy*
-
Tuberculosis, Pulmonary / immunology
Substances
-
Anti-Bacterial Agents
-
Antitubercular Agents